Literature DB >> 9888449

H-7 increases trabecular facility and facility after ciliary muscle disinsertion in monkeys.

B Tian1, B T Gabelt, J A Peterson, J A Kiland, P L Kaufman.   

Abstract

PURPOSE: To determine the effects of the serine-threonine kinase inhibitor H-7 on total outflow facility in iridectomized + ciliary muscle (CM)- disinserted, and on trabecular facility in normal, monkey eyes.
METHODS: Total outflow facility was determined by two-level constant pressure perfusion of the anterior chamber. Trabecular outflow facility was determined from accumulation in blood of intracamerally infused radioiodinated albumin at two intraocular pressure levels.
RESULTS: Three-hundred micromoles of intracameral H-7 doubled facility in iridectomized + CM- disinserted monkey eyes and contralateral iridectomized-only eyes. Four 5-microl drops of 400 mM H-7 applied topically followed 2 hours later by anterior chamber exchange for 10 minutes and intracameral infusion for 90 minutes with 100 microM H-7 increased trabecular and total outflow facility by 135%+/-29% and 105%+/-35% (n 5, P < 0.01, P < 0.05), respectively, compared with contralateral vehicle-treated eyes.
CONCLUSIONS: H-7 increases trabecular outflow facility in monkeys by a mechanism independent of the CM, presumably acting directly on the trabecular meshwork.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9888449

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Effects of cyclic intraocular pressure on conventional outflow facility.

Authors:  Renata F Ramos; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

2.  Comparisons of actin filament disruptors and Rho kinase inhibitors as potential antiglaucoma medications.

Authors:  Baohe Tian; Paul L Kaufman
Journal:  Expert Rev Ophthalmol       Date:  2012-04

3.  The mechanism of increasing outflow facility by rho-kinase inhibition with Y-27632 in bovine eyes.

Authors:  Zhaozeng Lu; Darryl R Overby; Patrick A Scott; Thomas F Freddo; Haiyan Gong
Journal:  Exp Eye Res       Date:  2007-11-05       Impact factor: 3.467

Review 4.  Trabecular meshwork stiffness in glaucoma.

Authors:  Ke Wang; A Thomas Read; Todd Sulchek; C Ross Ethier
Journal:  Exp Eye Res       Date:  2016-07-19       Impact factor: 3.467

Review 5.  The role of the actomyosin system in regulating trabecular fluid outflow.

Authors:  Baohe Tian; B'Ann T Gabelt; Benjamin Geiger; Paul L Kaufman
Journal:  Exp Eye Res       Date:  2008-08-27       Impact factor: 3.467

Review 6.  Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension.

Authors:  Angelo P Tanna; Mark Johnson
Journal:  Ophthalmology       Date:  2018-07-12       Impact factor: 12.079

Review 7.  The Application of Nitric Oxide for Ocular Hypertension Treatment.

Authors:  Binze Han; Maomao Song; Liping Li; Xinghuai Sun; Yuan Lei
Journal:  Molecules       Date:  2021-12-01       Impact factor: 4.411

8.  Multiomics analysis reveals the mechanical stress-dependent changes in trabecular meshwork cytoskeletal-extracellular matrix interactions.

Authors:  Avinash Soundararajan; Ting Wang; Rekha Sundararajan; Aruna Wijeratne; Amber Mosley; Faith Christine Harvey; Sanjoy Bhattacharya; Padmanabhan Paranji Pattabiraman
Journal:  Front Cell Dev Biol       Date:  2022-09-13

9.  Dose- and time-dependent effects of actomyosin inhibition on live mouse outflow resistance and aqueous drainage tissues.

Authors:  MinHee K Ko; Eun Kyoung Kim; Jose M Gonzalez; James C Tan
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.